Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $312.39 | $7.16 | 4,264.37% | 6,247.80x | 219.82x | 6.92x | 8.38x | 16.83x | $529.27M | 1.54% | $4.13B | 37.48 | $32.47B | 102.10 | ||
| CORT | CORCEPT THERAPEUTICS INC | $82.65 | $27.10 | 205.04% | 82.65x | 83.54x | 11.55x | 13.76x | 1.44x | $162.57M | 1.90% | $631.90M | 6.10 | $8.58B | 129.97 | ||
| NVO | NOVO NORDISK A S | $52.40 | $138.94 | -62.29% | 14.57x | 2.21x | 4.79x | 8.89x | 0.16x | $9.34B | 4.01% | $26.18B | 5.89 | $243.49B | 9.81 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $400.59 | $30.16 | 1,228.34% | 1,292.23x | 213.97x | 16.40x | 226.27x | 5.23x | $221.36M | 0.42% | $233.89M | 1.78 | $54.65B | 359.69 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.87 | $11.76 | -24.59% | 18.48x | 6.79x | 5.88x | 3.75x | 0.37x | -$23.64M | -4.77% | $133.17M | 2.38 | $507.64M | 7.55 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.00 | $14.97 | 180.64% | 85.71x | 42.09x | 5.25x | 5.95x | 1.28x | $101.73M | 3.24% | $535.38M | 7.17 | $3.02B | 56.34 | ||
| GMAB | GENMAB A | $33.42 | $106.20 | -68.53% | 14.26x | 1.86x | 6.02x | 3.73x | 0.13x | $1.19B | 5.57% | $5.75B | 8.96 | $19.84B | 9.92 | ||
| ARGX | ARGENX SE | $844.92 | $282.99 | 198.57% | 33.76x | 47.17x | 27,255.48x | 7.19x | 2.27x | $467.72M | 0.91% | $7.17B | 117.50 | $49.17B | 60.60 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $195.83 | $65.96 | 196.89% | 84.77x | 26.25x | 15.26x | 4.06x | 1.38x | $30.76M | 0.80% | $950.17M | 48.53 | $4.17B | 40.44 | ||
| VCEL | VERICEL CORP | $37.66 | $6.69 | 463.34% | 144.85x | 137.40x | 7.35x | 5.92x | 2.69x | $20.38M | 1.07% | $321.86M | 6.38 | $1.90B | 64.90 | ||
| TECH | BIO-TECHNE CORP | $59.22 | $16.44 | 260.19% | 118.44x | 29.29x | 7.57x | 4.69x | 1.62x | $224.06M | 2.43% | $1.97B | 12.65 | $9.48B | 42.90 | ||
| RPRX | ROYALTY PHARMA PLC | $39.22 | $42.62 | -7.98% | 22.28x | 8.15x | 7.21x | 2.35x | 0.45x | $2.11B | 12.47% | $9.62B | 22.28 | $30.65B | 29.35 | ||
| KRYS | KRYSTAL BIOTECH INC | $252.17 | $68.14 | 270.10% | 36.55x | 40.36x | 19.56x | 6.43x | 3.32x | $166.02M | 2.27% | $1.14B | 39.30 | $6.93B | 35.85 | ||
| VCYT | VERACYTE INC | $42.49 | $9.31 | 356.41% | 108.95x | 80.11x | 6.76x | 2.67x | 2.23x | $98.21M | 2.94% | $1.26B | 15.98 | $3.08B | 54.07 | ||
| CRMD | CORMEDIX INC | $12.53 | $13.34 | -6.07% | 5.52x | 5.01x | 4.44x | 2.64x | 27.47x | $74.42M | 7.82% | $374.13M | 4.93 | $1.09B | 9.69 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.81 | $1.31 | 38.14% | 25.86x | 71.54x | 2.32x | 2.75x | 0.74x | -$11.69M | -8.12% | $52.91M | 0.67 | $140.09M | 15.79 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.26 | $0.76 | 856.54% | 103.71x | 47.45x | 6.15x | 6.86x | 7.61x | $3.05M | 0.47% | $101.92M | 1.12 | $660.14M | 49.90 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $16.25 | $8.25 | 97.03% | 28.02x | 20.69x | 8.06x | 5.86x | 1.23x | $119.87M | 5.59% | $365.77M | 2.78 | $2.15B | 20.74 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.95 | $43.21 | 38.73% | 22.04x | 19.99x | 3.72x | 1.90x | 0.81x | $832.13M | 7.23% | $6.06B | 31.54 | $10.86B | 14.06 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.87 | $75.83 | -9.18% | 14.08x | 10.76x | 6.50x | 16.07x | 0.54x | $602.40M | 7.46% | $503.92M | 4.30 | $9.19B | 10.87 | ||
| EXEL | EXELIXIS INC | $46.24 | $30.10 | 53.61% | 18.80x | 17.25x | 5.42x | 5.74x | 1.08x | $779.77M | 6.28% | $2.16B | 8.05 | $12.20B | 13.15 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $462.90 | $171.37 | 170.12% | 32.35x | 24.77x | 10.09x | 6.78x | 1.94x | $3.34B | 2.82% | $17.32B | 67.76 | $114.34B | 24.53 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.13 | $37.09 | 2.81% | 11.80x | 11.70x | 2.66x | 2.63x | 0.77x | $296.89M | 13.53% | $835.12M | 14.51 | $1.72B | 6.37 | ||
| ADMA | ADMA BIOLOGICS INC | $19.28 | $8.51 | 126.58% | 21.91x | 32.31x | 9.41x | 10.64x | 2.10x | $40.73M | 0.89% | $431.19M | 1.81 | $4.60B | 26.73 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.64 | $3.34 | 98.65% | 24.59x | 35.78x | 4.25x | 7.50x | 1.38x | $21.15M | 3.99% | $70.68M | 0.89 | $468.68M | 20.65 | ||
| MNKD | MANNKIND CORP | $5.79 | $1.44 | 300.93% | 57.90x | 72.74x | 5.66x | -39.91x | 2.48x | $43.39M | 2.44% | -$44.55M | -0.15 | $2.01B | 27.47 | ||
| INCY | INCYTE CORP | $100.11 | $68.52 | 46.09% | 16.57x | 14.34x | 4.07x | 4.23x | 1.11x | $1.20B | 6.11% | $4.65B | 23.77 | $17.23B | 10.24 | ||
| INVA | INNOVIVA INC | $19.80 | $15.47 | 27.97% | 10.48x | 9.24x | 3.52x | 1.47x | 1.63x | $196.54M | 14.37% | $1.01B | 14.63 | $1.26B | 5.87 | ||
| UTHR | UNITED THERAPEUTICS CORP | $507.16 | $201.29 | 151.96% | 17.81x | 18.37x | 7.10x | 3.31x | 5.21x | $1.12B | 5.05% | $6.59B | 150.46 | $20.50B | 11.56 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.35 | $12.32 | 97.64% | 13.60x | 15.13x | 5.16x | 3.25x | 4.66x | $234.54M | 7.86% | $920.25M | 7.51 | $2.31B | 7.12 | ||
| MDXG | MIMEDX GROUP INC | $6.90 | $2.79 | 147.17% | 24.64x | 16.11x | 2.60x | 4.28x | 2.19x | $66.82M | 6.54% | $238.95M | 1.61 | $898.04M | 12.98 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $784.97 | $372.11 | 110.95% | 18.07x | 17.88x | 5.71x | 2.66x | 2.42x | $4.22B | 5.19% | $30.96B | 298.82 | $82.70B | 14.48 | ||
| XOMA | XOMA ROYALTY CORP | $26.06 | $4.82 | 440.54% | 32.17x | 23.44x | 6.71x | 3.67x | 79.47x | -$12.41M | -3.92% | $87.94M | 7.25 | $364.14M | 13.61 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.